ARCHIVES

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

June 23, 2000

Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP

June 24, 1994

Tracors’ Prime Contract Includes $1 Million for Additional Tests

May 17, 1974

CCOP Review Committees Listed

February 6, 1987

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009

NCI, EORTC Offer Support For Russian Cancer Researchers

April 14, 1995